Bupivacaine Hydrochloride
- Product NDC
- 52584-160
- 11-digit product format
- 525840160
- Labeler code
- 52584
- Product ID
- 52584-160_3dbb9b88-8e63-4bd3-818e-0b2751337283
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupivacaine Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INFILTRATION; PERINEURAL
- Labeler
- General Injectables & Vaccines, Inc
- Application
- ANDA070590
- Marketing category
- ANDA
- Marketing start
- 2010-07-01
- Marketing end
- 2024-02-01
- Substance
- BUPIVACAINE HYDROCHLORIDE
- Active strength
- 3 mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 52584-160 | D | Discontinued by firm | 2026-07-31 | ||
| excluded package | package | 52584-160 | 52584-160-01 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A070590-001 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 1987-02-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A070590-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A070590-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 1987-02-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A070590-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 02a845c3-4521-4926-e397-25ab536e7cf6 | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | 070590 ANDA070590 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Henry Schein, Inc | 3c0f567f-b7f8-4ee8-bfb2-61cd82550498 | 2025-10-30 | Boxed warning, Warnings, Adverse reactions | 070590 ANDA070590 |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 950d82b6-76a1-0c08-e053-2a95a90a3a92 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 070590 ANDA070590 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | ada6a9bf-f7cb-035a-e053-2a95a90a6a3d | 2023-05-03 | Warnings, Adverse reactions | 070590 ANDA070590 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Bupivacaine Hydrochloride | ACTIVE INGREDIENT | 7TQO7W3VT8 | BUPIVACAINE HYDROCHLORIDE INJECTION [GENERAL INJECTABLES & VACCINES, INC] | 2 | |
| Bupivacaine | ACTIVE MOIETY | Y8335394RO | BUPIVACAINE HYDROCHLORIDE INJECTION [GENERAL INJECTABLES & VACCINES, INC] | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 52584-160-01 | 52584016001 | 1 VIAL, MULTI-DOSE in 1 BAG (52584-160-01) > 50 mL in 1 VIAL, MULTI-DOSE | 2016-09-09 | 0000-00-00 | No | No | Current |